Psoriasis and risk of heart failure: A nationwide cohort study

European Journal of Heart Failure

Volumn 16, Issue 7, 2014, Pages 743-748

  Khalid, Usman ^a   Ahlehoff, Ole ^a,b   Gislason, Gunnar Hilmar ^a,c,d   Kristensen, Søren Lund ^a   Skov, Lone ^d,e   Torp Pedersen, Christian ^d,f   Hansen, Peter Riis ^a,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AALBORG UNIVERSITY   (Denmark)

Author keywords

Cardiovascular risk; Epidemiology; Heart failure; Inflammation; Psoriasis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYPOCHOLESTEROLEMIC AGENT; LOOP DIURETIC AGENT; METHOTREXATE; RETINOID; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VITAMIN D; ANTIRHEUMATIC AGENT; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; SOCIAL STATUS; ARTHRITIS, PSORIATIC; DENMARK; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CARDIOVASCULAR AGENTS; COHORT STUDIES; DENMARK; HEART FAILURE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84903762764     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.113     Document Type: Article

References (43)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Rachakonda TD, Schupp CW, Armstrong AW,. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 2014; 70: 512-516.
3. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ,. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 2009; 161: 1-7.
4. Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, Olesen JB, Abildstrom SZ, Skov L, Torp-Pedersen C, Hansen PR,. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.
5. Samarasekera EJ, Neilson JM, Warren RB, Parnham J, Smith CH,. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. J Invest Dermatol 2013; 133: 2340-2346.
6. Yeung H, Takeshita J, Mehta NN, Takeshirta J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, Shin DB, Attor R, Troxel AB, Gelfand JM,. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 2013; 149: 1173-1179.
7. Armstrong EJ, Harskamp CT, Armstrong AW,. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2013; 2: e000062.
8. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK,. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161: 996-1002. (Pubitemid 32295654)
9. King M, Kingery J, Casey B,. Diagnosis and evaluation of heart failure. Am Fam Physician 2012; 85: 1161-1168.
10. Blum A, Miller H,. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 2001; 52: 15-27. (Pubitemid 32195312)
11. Damas JK, Gullestad L, Aukrust P,. Cytokines as new treatment targets in chronic heart failure. Curr Control Trials Cardiovasc Med 2001; 2: 271-277. (Pubitemid 34100478)
12. Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, Liu Y, Hoffmann U, Bauer DC, Newman AB, Kritchevsky SB, Harris TB, Butler J,. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol 2010; 55: 2129-2137.
13. Paulus WJ, Tschope C,. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013; 62: 263-271.
14. Dowlatshahi EA, Kavousi M, Nijsten T, Ikram MA, Hofman A, Franco OH, Wakkee M,. Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the rotterdam study. J Invest Dermatol 2013; 133: 2347-2354.
15. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT,. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009; 68: 1131-1135.
16. Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, Fraeman K, Bala M,. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008; 217: 27-37. (Pubitemid 351896565)
17. Maradit-Kremers H, Dierkhising RA, Crowson CS, Icen M, Ernste FC, McEvoy MT,. Risk and predictors of cardiovascular disease in psoriasis: a population-based study. Int J Dermatol 2013; 52: 32-40.
18. Yang YW, Keller JJ, Lin HC,. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol 2011; 165: 1037-1043.
19. von EE, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP,. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
20. Gaist D, Sorensen HT, Hallas J,. The Danish prescription registries. Dan Med Bull 1997; 44: 445-448. (Pubitemid 27382061)
21. Ahlehoff O, Gislason GH, Jorgensen CH, Lindhardsen J, Charlot M, Olesen JB, Abildstrom SZ, Skov L, Torp-Pedersen C, Hansen PR,. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J 2012; 33: 2054-2064.
22. Khalid U, Hansen PR, Gislason GH, Lindhardsen J, Kristensen SL, Winther SA, Skov L, Torp-Pedersen C, Ahlehoff O,. Psoriasis and new-onset diabetes: a Danish nationwide cohort study. Diabetes Care 2013; 36: 2402-2407.
23. Kumler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Kober L, Torp-Pedersen C,. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008; 10: 658-660.
24. Mard S, Nielsen FE,. Positive predictive value and impact of misdiagnosis of a heart failure diagnosis in administrative registers among patients admitted to a University Hospital cardiac care unit. Clin Epidemiol 2010; 2: 235-239.
25. Davidovici BB, Sattar N, Prinz JC, Puig L, Emery P, Barker JN, van de Kerkhof P, Stahle M, Nestle FO, Girolomoni G, Krueger JG,. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
26. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG,. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-1211. (Pubitemid 351543220)
27. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV,. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167-2172. (Pubitemid 44749774)
28. Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR,. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study. PLoS One 2013; 8: e56944.
29. Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, Hansen PR,. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011; 70: 929-934.
30. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE,. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 412-420. (Pubitemid 40216304)
31. Schoenfeld SR, Kasturi S, Costenbader KH,. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum 2013; 43: 77-95.
32. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT,. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-331.
33. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB,. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245.
34. Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T,. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol 2013; 169: 266-282.
35. Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW,. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des 2014; 20: 513-28.
36. Gisondi P, Fantin F, Del GM, Valbusa F, Marino F, Zamboni M, Girolomoni G,. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-113.
37. Shang Q, Tam LS, Yip GW, Sanderson JE, Zhang Q, Li EK, YU CM,. High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 2011; 38: 1363-1370.
38. Gunes Y, Tuncer M, Calka O, Sanderson JE, Zhang Q, Li EK, Yu CM,. Increased frequency of pulmonary hypertension in psoriasis patients. Arch Dermatol Res 2008; 300: 435-440.
39. Hunt SA, Abraham WT, Chin MH, eldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B., ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
40. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, Kaufmann R, Vogl TJ, Boehncke WH,. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-276. (Pubitemid 46095954)
41. Yiu KH, Yeung CK, Zhao CT, Chan JC, Siu CW, Tam S, Wong CS, Yan GH, Yue WS, Khong PL, Chan HH, Tse HF,. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis. J Intern Med 2013; 273: 273-282.
42. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT,. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003; 107: 3133-3140. (Pubitemid 36793081)
43. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer J.S, Colucci W.S, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T,. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004; 109: 1594-1602. (Pubitemid 38451714)